ArticleEndocrine, metabolic & immune disorders drug targets2026
UBE2M Identified by CRISPR Screening as a Key Regulator of Cisplatin-Induced Acute Kidney Injury via the p53 Pathway
Cheng Yuan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.